FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3023714464> ?p ?o ?g. }

• W3023714464 endingPage "32" @default.
• W3023714464 startingPage "27" @default.
• W3023714464 abstract "Relatively little is known about endocrine function, bone mineral health, and growth during oral iron chelation therapy in β-thalassemia major patients (TM) on treatment with deferasirox.To study the frequency of endocrine complications, IGF-1 levels and final adult standing height (FA-Ht) in patients with BTM in two groups of adult patients.The first group (Group A; 15 patients, 6 females and 9 males) received oral iron chelation therapy (OIC) with deferasirox for 6 years before puberty; the second group (Group B;40 patients) attained the FA-Ht before the use of OIC (iron chelation therapy with deferoxamine (DFO) given subcutaneously, since the age of 2 years). In both groups liver iron concentration was measured using FerriScan ® R2-MRI method. Furthermore, the FA-Ht, bode mass index (BMI), and insulin growth factor-1 (IGF-1) in a selected group of adult patients [9 with normal growth hormone (GH) secretion (GHN) and 8 with GH deficiency (GHD; peak GH response to provocative test with clonidine: < 7 ng/ml), who were on iron chelation therapy with DFO given subcutaneously that was changed to oral deferasirox during the last 5-6 years. These 15 patients were not treated with rhGH.Adults with BTM who received OIC for 6 years or more before attaining their FA-Ht, had lower liver iron concentration (LIC) assessed by FerriScan® R2-MRI, fasting glucose level (FBG) and liver enzymes (ALT and AST), and a better FA-Ht expressed in standard deviation score (FA-Ht-SDS), and higher IGF-1 SDS versus those who did not receive OIC before attaining FA-Ht. The prevalence of endocrinopathies, including hypothyroidism and hypogonadism were significantly lower in Group A versus Group B. Comparison between the group with normal GHN and those with GHD showed that the FA-Ht-SDS of those with GHD (159.1± 6.42 cm). Ht-SDS = -2.5 ± 0.9) was significantly decreased compared to the group with NGH (Ht = 163.5 ± 5.2 cm, Ht-SDS = -1.74 ± 0.83). The IGF-1-SDS did not differ between the two groups. Neither ferritin level nor IGF-1 concentrations were correlated with the Ht-SDS. The final FA-Ht-SDS correlated significantly with the peak GH secretion (r = 0.788, p = 0.0008). The FA-Ht-SDS were positively related to their mid-parental height (r=0.58, P <0.01).The use of OIC years before the end of puberty was associated with a significantly lower prevalence of endocrinopathies, improvement of LIC and FA-Ht. The final adult height of patients with BTM and GHD was significantly shorter compared to their pears with NGH. rhGH therapy can be recommended for the treatment of thalassemic children and adolescents with GHD in addition to proper blood transfusion and intensive chelation to improve their final height." @default.
• W3023714464 created "2020-05-13" @default.
• W3023714464 creator A5032603175 @default.
• W3023714464 creator A5048664693 @default.
• W3023714464 creator A5072205501 @default.
• W3023714464 date "2018-02-16" @default.
• W3023714464 modified "2023-10-18" @default.
• W3023714464 title "Final adult height and endocrine complications in young adults with β-thalassemia major (TM) who received oral iron chelation (OIC) in comparison with those who did not use OIC." @default.
• W3023714464 cites W1498809087 @default.
• W3023714464 cites W1931066741 @default.
• W3023714464 cites W1982563696 @default.
• W3023714464 cites W1984997586 @default.
• W3023714464 cites W1987640177 @default.
• W3023714464 cites W1988185165 @default.
• W3023714464 cites W1995812599 @default.
• W3023714464 cites W2005746290 @default.
• W3023714464 cites W2012426906 @default.
• W3023714464 cites W2030120006 @default.
• W3023714464 cites W2031133718 @default.
• W3023714464 cites W2038682678 @default.
• W3023714464 cites W2078722785 @default.
• W3023714464 cites W2093099445 @default.
• W3023714464 cites W2103778162 @default.
• W3023714464 cites W2108344872 @default.
• W3023714464 cites W2117876502 @default.
• W3023714464 cites W2158138334 @default.
• W3023714464 cites W2296530714 @default.
• W3023714464 cites W2411063319 @default.
• W3023714464 cites W2504967537 @default.
• W3023714464 cites W79811962 @default.
• W3023714464 doi "https://doi.org/10.23750/abm.v89i2-s.7084" @default.
• W3023714464 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6179038" @default.
• W3023714464 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29451226" @default.
• W3023714464 hasPublicationYear "2018" @default.
• W3023714464 type Work @default.
• W3023714464 sameAs 3023714464 @default.
• W3023714464 citedByCount "3" @default.
• W3023714464 countsByYear W30237144642022 @default.
• W3023714464 countsByYear W30237144642023 @default.
• W3023714464 crossrefType "journal-article" @default.
• W3023714464 hasAuthorship W3023714464A5032603175 @default.
• W3023714464 hasAuthorship W3023714464A5048664693 @default.
• W3023714464 hasAuthorship W3023714464A5072205501 @default.
• W3023714464 hasConcept C126322002 @default.
• W3023714464 hasConcept C134018914 @default.
• W3023714464 hasConcept C2776517179 @default.
• W3023714464 hasConcept C2776672577 @default.
• W3023714464 hasConcept C2777218474 @default.
• W3023714464 hasConcept C2777799968 @default.
• W3023714464 hasConcept C2779952775 @default.
• W3023714464 hasConcept C2781053155 @default.
• W3023714464 hasConcept C2984496839 @default.
• W3023714464 hasConcept C46699223 @default.
• W3023714464 hasConcept C71315377 @default.
• W3023714464 hasConcept C71924100 @default.
• W3023714464 hasConcept C90924648 @default.
• W3023714464 hasConceptScore W3023714464C126322002 @default.
• W3023714464 hasConceptScore W3023714464C134018914 @default.
• W3023714464 hasConceptScore W3023714464C2776517179 @default.
• W3023714464 hasConceptScore W3023714464C2776672577 @default.
• W3023714464 hasConceptScore W3023714464C2777218474 @default.
• W3023714464 hasConceptScore W3023714464C2777799968 @default.
• W3023714464 hasConceptScore W3023714464C2779952775 @default.
• W3023714464 hasConceptScore W3023714464C2781053155 @default.
• W3023714464 hasConceptScore W3023714464C2984496839 @default.
• W3023714464 hasConceptScore W3023714464C46699223 @default.
• W3023714464 hasConceptScore W3023714464C71315377 @default.
• W3023714464 hasConceptScore W3023714464C71924100 @default.
• W3023714464 hasConceptScore W3023714464C90924648 @default.
• W3023714464 hasIssue "2-S" @default.
• W3023714464 hasLocation W30237144641 @default.
• W3023714464 hasOpenAccess W3023714464 @default.
• W3023714464 hasPrimaryLocation W30237144641 @default.
• W3023714464 hasRelatedWork W1507673441 @default.
• W3023714464 hasRelatedWork W2050427403 @default.
• W3023714464 hasRelatedWork W2051936894 @default.
• W3023714464 hasRelatedWork W2109853368 @default.
• W3023714464 hasRelatedWork W2150640700 @default.
• W3023714464 hasRelatedWork W2156469375 @default.
• W3023714464 hasRelatedWork W2187575468 @default.
• W3023714464 hasRelatedWork W2397435675 @default.
• W3023714464 hasRelatedWork W2582129105 @default.
• W3023714464 hasRelatedWork W3023714464 @default.
• W3023714464 hasVolume "89" @default.
• W3023714464 isParatext "false" @default.
• W3023714464 isRetracted "false" @default.
• W3023714464 magId "3023714464" @default.
• W3023714464 workType "article" @default.